Gargiulo, Giuseppe; Nagler, Michael; Valgimigli, Marco (2021). Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial". Circulation, 143(13), e797-e798. American Heart Association 10.1161/CIRCULATIONAHA.120.051945
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Response_by_Gargiulo.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (149kB) | Request a copy |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Nagler, Michael |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1524-4539 |
Publisher: |
American Heart Association |
Language: |
English |
Submitter: |
Karin Balmer |
Date Deposited: |
30 Nov 2021 09:31 |
Last Modified: |
05 Dec 2022 15:55 |
Publisher DOI: |
10.1161/CIRCULATIONAHA.120.051945 |
PubMed ID: |
33779272 |
BORIS DOI: |
10.48350/161535 |
URI: |
https://boris.unibe.ch/id/eprint/161535 |
Actions (login required)
 |
Edit item |